Tarbox Family Office’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
BC
Tarbox Family Office's XBI Position: Q4 2021 in Review
Tarbox Family Office sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2021, closing a stake of 1,000 shares — an estimated $126K sold.
Tarbox Family Office first reported a position in XBI in Q2 2021 and held it in 2 quarters. The position peaked at $135K in Q2 2021. 702 funds tracked by Wall St. Rank hold XBI as of Q4 2021.
- Tarbox Family Office reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2021 after selling out during the quarter.
- Tarbox Family Office sold 1,000 State Street SPDR S&P Biotech ETF shares in Q4 2021, an estimated $126K.
- Tarbox Family Office first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and held it in 2 quarters.
- Tarbox Family Office's State Street SPDR S&P Biotech ETF position peaked at $135K in Q2 2021.
- 702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.
Based on Tarbox Family Office's 13F filing for Q4 2021, filed 6 Jan 2022.